Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript March 14, 2024 Quoin Pharmaceuticals, Ltd.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 211,538 | $1,023,844 | 0.11% | |
| 2. | Stonepine Capital Timothy P. Lynch | 199,486 | $965,512 | +274% | 0.54% |
| 3. | Millennium Management Israel Englander | 112,323 | $543,643 | +48% | 0% |
| 4. | SummitTX Capital Caroline Cooley | 100,300 | $485,452 | 0.01% | |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 76,446 | $369,999 | -4% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.88 | 20,490 | $99,991.20 | 37,709 | 2026-08-31 | Filing | |
| $4.88 | 20,490 | $99,991.20 | 37,713 | 2026-08-31 | Filing | |
| $4.88 | 10,244 | $49,990.72 | 10,684 | 2026-08-31 | Filing | |
| $4.88 | 6,146 | $29,992.48 | 40,364 | 2026-08-31 | Filing | |
| $8.49 | 15,152 | $128,640.48 | 15,153 | 2025-10-14 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.73 | 297 | $217.40 | 53 | 2024-06-07 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 214,987 | $1,040,537 | 0.82% | |
| 2. | 75,000 | $363,000 | 0% | |
| 3. | 59,838 | $289,616 | 0% | |
| 4. | 21,469 | $103,910 | 0% | |
| 5. | 15,006 | $72,629 | 0% |